Press Releases

VANCOUVER, British Columbia, Jan. 29, 2020 /PRNewswire/ --  MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTC: MYMMF) ("MYM" or the "Company") announces it has closed the second tranche of the non-brokered private placement previously announced on January 14, 2020. The second tranche issued 3,683,416 units at a price of

INDIANAPOLIS, Jan. 29, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) for selpercatinib (LOXO-292), for the treatment of patients wit

AACHEN, Germany and BOSTON, Jan. 29, 2020 /PRNewswire/ -- Grünenthal announced today that it has officially inaugurated its Innovation Hub in Boston, Massachusetts to strengthen and expand its network with leading scientists and institutions. With its Innovation Hubs, Grünenthal

DENVER, Jan. 29, 2020 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Monday, February 10, 2020, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.   

STOCKHOLM, Jan. 29, 2020 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, announced today that an order of more Rabeximod substance will be placed earlier than expected with the primary objective of providing optimal conditions for conducting the clinical phase IIb trial.  This proactive and strategic decision follows the initiation of pre

PLYMOUTH MEETING, Pa., Jan. 29, 2020 /PRNewswire/ -- Geneos Therapeutics announced today that its personalized neoantigen-targeting vaccine, GNOS-PV02 (based on its proprietary GT-EPIC™ platform), will be evaluated in a clinical trial for patients with advanced Hepatocellular Carcinoma (HCC). GNOS-PV02 is a tumor-specific DNA plasmid product designed and manuf

OX338 demonstrated improved bioavailability and tolerability compared to commercially available reference productFurther work required to optimise product formulation UPPSALA, Sweden, Jan. 29, 2020 /PRNewswire/ -- Orexo AB (publ.) today announces promising results from its OX338 phar

CHICAGO, Jan. 29, 2020 /PRNewswire/ -- The American Lung Association's 2020 "State of Tobacco Control" report finds that the federal government can do more to address the youth vaping epid

LOS ANGELES, Jan. 28, 2020 /PRNewswire/ -- Hawkeye Systems, Inc. (OTCQB:  

Director appointment advances Company goal to broaden diversity and industry experience on its Board, by adding an entrepreneurial executive with three decades of experience leading private and public companies across the health and wellness markets TORONTO and LAS VEGAS, Jan. 28, 2020 /PRNewswire/ - Flower O